tiprankstipranks
Trending News
More News >
HTG Molecular Diagnostics (HTGMQ)
OTHER OTC:HTGMQ
US Market

HTG Molecular Diagnostics (HTGMQ) Income Statement

Compare
460 Followers

HTG Molecular Diagnostics Income Statement

Last quarter (Q1 2023), HTG Molecular Diagnostics's total revenue was $1.03M, a decrease of -12.83% from the same quarter last year. In Q1, HTG Molecular Diagnostics's net income was $-5.05M. See HTG Molecular Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 6.37M$ 8.91M$ 8.55M$ 19.20M$ 21.50M
Gross Profit
$ 1.79M$ 4.81M$ 4.56M$ 10.29M$ 16.41M
Operating Expenses
$ 22.62M$ 22.64M$ 24.56M$ 29.25M$ 32.57M
Depreciation and Amortization
$ 587.14K$ 721.25K$ 1.35M$ 1.26M$ 1.47M
EBITDA
$ -20.14M$ -15.36M$ -18.48M$ -17.08M$ -15.10M
Operating Income
$ -20.83M$ -17.82M$ -19.59M$ -18.96M$ -16.16M
Other Income/Expenses
$ -754.04K$ 701.13K$ -1.27M$ -334.18K$ -291.16K
Pretax Income
$ -21.58M$ -17.12M$ -20.86M$ -19.29M$ -16.45M
Net Income
$ -21.59M$ -17.15M$ -20.87M$ -19.30M$ -16.45M
Per Share Metrics
Basic EPS
$ -24.28$ -29.66$ -54.12$ -91.17$ -107.61
Diluted EPS
$ -24.28$ -29.66$ -54.12$ -91.17$ -107.61
Weighted Average Shares Outstanding
889.28K 578.01K 385.66K 211.66K 152.91K
Weighted Average Shares Outstanding (Diluted)
889.28K 578.01K 385.66K 211.66K 152.91K
Currency in USD

HTG Molecular Diagnostics Earnings and Revenue History